CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to improve treatment for high-risk retroperitoneal sarcomas by evaluating the effectiveness of neoadjuvant chemotherapy before surgery. It combines a clinical trial with observational data to assess outcomes and cost-effectiveness, potentially establishing a new standard of care for this rare cancer.
Retroperitoneal sarcomas are rare diseases refractory to treatment with dismal prognosis.
Surgery is the only standard approach to primary disease.
We are proposing an innovative pragmatic approach supplementing a standard phase III clinical trial with an observational cohort.
It is proposed to amend the ongoing phase III EORTC clinical trial STRASS2 investigating the added value of neoadjuvant chemotherapy before surgery for high-risk retroperitoneal sarcoma and to add an observational arm STRE…
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Hungary, Budapest
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
Guests see up to 5 keywords.
